Episode #70: How an Endocrinologist Uses Peptides and Why Peptides Might be Banned by the FDA

About this video

Endocrinologist Edwin Lee, co-founder of the Clinical Peptide Society, describes how he moved from conventional practice toward preventive, peptide-informed medicine. He presents a small, unpublished review of his own patients in which he claims BPC-157 was associated with improvement in knee pain, and discusses case anecdotes, regenerative versus purely anti-inflammatory approaches, and why he argues route and injury severity should shape expectations, while noting the work was subjective and not a controlled trial. Much of the episode is devoted to regulatory pressure on compounded peptides in the United States, Lee’s advocacy campaigning to preserve access, and his argument that losing certain peptides would be a loss for patients.

Key takeaways

• Weigh small, subjective patient series differently from controlled clinical trials
• Ask whether an approach aims at symptom relief or at tissue repair
• Expect regulatory status to shape peptide access as much as the science does
• Check a clinician’s advocacy and commercial interests when evaluating their claims

Episode details: published November 23, 2021 · 1.5K views · 1:15:49 long. Summary written by Self Growth Videos from the episode itself. The longevity and peptide concepts described are Nathalie Niddam’s or her guests’, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Niddam promotes peptide products through affiliate arrangements with peptide vendors, a commercial conflict; Self Growth Videos reproduces none of her codes.

← Previous: EP 54: New Peptide for Immune Support, Synthetic Bioregulator Update with Jean-Francois Tremblay · Next: Episode # 75: Nitric Oxide is Foundational for Health: How to Make Sure You’re Getting Enough →

All Nathalie Niddam videos · Nathalie Niddam profile · Nathalie Niddam (official site)